Filing
Registration
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 1, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia
Lobbyists on this filing
3
-
RICHARD BURR Former member of Congress New on this filingPreviously held: U.S. Senator
-
MARGARET MARTIN New on this filingPreviously held: Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr
-
MICHAEL SORENSEN New on this filingPreviously held: Scheduler and other positions, Sen. Richard Burr; Intern, Rep. John Boehner; Intern, Rep. Mike Kelly
Lobbying activity
2
Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.
Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.